Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas

Cancer Gene Therapy

Volumn 14, Issue 10, 2007, Pages 836-846

  Benitez J A ^a   Arregui, L ^a   Vergara, P ^a   Segovia, J ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Apoptosis; Cell cycle; Gas1; GFAP promoter; Gliomas; p53

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH ARREST SPECIFIC PROTEIN 1; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GENE THERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MEMBRANE PROTEINS; MICE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

RATTUS;

EID: 34548660343     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7701076     Document Type: Article

References (67)

1. Lopez-Gonzalez MA, Sotelo J. Brain tumors in Mexico: characteristics and prognosis of glioblastoma. Surg Neurol 2000; 53: 157-162.
2. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DM, Cavenee WK et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-1333.
3. Barzon L, Zanusso M, Colombo F, Palu G. Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther 2006; 13: 539-554.
4. Lawler SE, Peruzzi PP, Chiocca EA. Genetic strategies for brain tumor therapy. Cancer Gene Ther 2006; 13: 225-233.
5. Stebel M, Vatta P, Ruaro ME, Del Sal G, Parton RG, Schneider C. The growth suppressing Gas1 product is a GPI-linked protein. FEBS Lett 2000; 481: 152-158.
6. DelSal G, Ruaro EM, Utrera R, Cole CN, Levine AJ, Schneider C. Gas1-induced growth suppression requires a transactivation-independent P53 function. Mol Cell Biol 1995; 15: 7152-7160.
7. Lee KKH, Leung AKC, Tang MK, Cai DQ, Schneider C, Brancolini C et al. Functions of the growth arrest specific 1 gene in the development of the mouse embryo. Dev Biol 2001; 234: 188-203.
8. DelSal G, Ruaro ME, Philipson L, Schneider C. The growth arrest-specific gene, Gas1, is involved in growth suppression. Cell 1992; 70: 595-607.
9. Mellstrom B, Cena V, Lamas M, Perales C, Gonzalez C, Naranjo JR. Gas1 is induced during and participates in excitotoxic neuronal death. Mol Cell Neurosci 2002; 19: 417-429.
10. Zamorano A, Lamas M, Vergara P, Naranjo JR, Segovia J. Transcriptionally mediated gene targeting of Gas1 to glioma cells elicits growth arrest and apoptosis. J Neurosci Res 2003; 71: 256-263.
11. Zamorano A, Mellstrom B, Vergara P, Naranjo JR, Segovia J. Glial-specific retrovirally mediated Gas1 gene expression induces glioma cell apoptosis and inhibits tumor growth in vivo. Neurobiol Dis 2004; 15: 483-491.
12. Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S et al. Phase I trial of adenovirus-mediated P53 gene therapy for recurrent glioma: biological and clinical results. J Clin Oncol 2003; 21: 2508-2518.
13. Martins CP, Brown-Swigart L, Evan GI. Modeling the therapeutic efficacy of P53 restoration in tumors. Cell 2006; 127: 1323-1334.
14. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of P53 function leads to tumour regression in vivo. Nature 2007; 445: 661-665.
15. Benitez JA, Segovia J. Gene therapy targeting in the central nervous system. Curr Gene Ther 2003; 3: 127-145.
16. Segovia J, Vergara P, Brenner M. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism. Gene Therapy 1998; 5: 1650-1655.
17. Vandier D, Rixe O, Brenner M, Gouyette A, Besnard F. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus thymidine kinase gene. Cancer Res 1998; 58: 4577-4580.
18. Vandier D, Rixe O, Besnard F, Kim M, Rikiyama T, Goldsmith M et al. Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter. Cancer Gene Ther 2000; 7: 1120-1126.
19. Sacchettoni SA, Benchaibi M, Sindou M, Belin MF, Jacquemont B. Glutamate-modulated production of GABA in immortalized astrocytes transduced by a glutamic acid decarboxylase-expressing retrovirus. Glia 1998; 22: 86-93.
20. Holland EC, Varmus HE. Basic fibroblast growth factor induces cell migration and proliferation after Glia-specific gene transfer in mice. Proc Natl Acad Sci USA 1998; 95: 1218-1223.
21. Do Thi NA, Saillour P, Ferrero L, Dedieu JF, Mallet J, Paunio T. Delivery of GDNF by an E1, E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease. Gene Therapy 2004; 11: 746-756.
22. Eng LF, Ghirnikar RS, Lee YL. Glial Fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 2000; 25: 1439-1451.
23. He TC, Zhou SB, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
24. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type P53. Science 1990; 249: 912-915.
25. Attal J, Theron MC, Houdebine LM. The optimal use of IRES (internal ribosome entry site) in expression vectors. Genet Anal 1999; 15: 161-165.
26. Ghattas IR, Sanes JR, Majors JE. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of 2 genes from a recombinant provirus in cultured-cells and in embryos. Mol Cell Biol 1991; 11: 5848-5859.
27. Choi-Lundberg DL, Bohn MC. Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) MRNA in rat. Brain Res Dev Brain Res 1995; 85: 80-88.
28. Garcia-Tovar CG, Perez A, Luna J, Mena R, Osorio B, Aleman V et al. Biochemical and histochemical analysis of 71KDa dystrophin isoform (Dp71f) in rat brain. Acta Histochem 2001; 103: 209-224.
29. He TC, Zhou SB, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
30. Houdebine LM, Attal J. Internal ribosome entry sites (IRESs): reality and use. Transgenic Res 1999; 8: 157-177.
31. Gu J, Andreeff M, Roth JA, Fang B. HTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gene Therapy 2002; 9: 30-37.
32. Gu J, Zhang LD, Huang XF, Lin TY, Yin M, Xu K et al. A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. Oncogene 2002; 21: 4757-4764.
33. Leung YF, Tam PO, Lee WS, Lam DS, Yam HF, Fan BJ et al. The dual role of dexamethasone on anti-inflammation and outflowresistance demonstrated in cultured human trabecular meshwork cells. Mol Vis 2003; 9: 425-439.
34. Lee CS, Buttitta L, Fan CM. Evidence that the WNT-inducible growth arrest-specific gene 1 encodes an antagonist of sonic hedgehog signaling in the somite. Proc Natl Acad Sci USA 2001; 98: 11347-11352.
35. Schueler-Furman O, Glick E, Segovia J, Linial M. Is GAS1 a co-receptor for the GDNF family of ligands? Trends Pharmacol Sci 2006; 27: 72-77.
36. Cabrera JR, Sanchez-Pulido L, Rojas AM, Valencia A, Manes S, Naranjo JR et al. Gas1 is related to the glial cell-derived neurotrophic factor family receptors alpha and regulates ret signaling. J Biol Chem 2006; 281: 14330-14339.
37. Mograbi B, Bocciardi R, Bourget I, Busca R, Rochet N, Farahi-Far D et al. Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway - importance for the rescue of neuroectodermic cells. J Biol Chem 2001; 276: 45307-45319.
38. Song H, Moon A. Glial cell-derived neurotrophic factor (GDNF) promotes low-grade Hs683 glioma cell migration through JNK, ERK-1/2 and P38 MAPK signaling pathways. Neurosci Res 2006; 56: 29-38.
39. Wiesenhofer B, Weis C, Humpel C. Glial cell line-derived neurotrophic factor (GDNF) is a proliferation factor for rat C6 glioma cells: evidence from antisense experiments. Antisense Nucleic Acid Drug Dev 2000; 10: 311-321.
40. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004; 306: 990-995.
41. Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 2005; 120: 237-248.
42. Yu LY, Jokitalo E, Sun YF, Mehlen P, Lindholm D, Saarma M et al. GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway. J Cell Biol 2003; 163: 987-997.
43. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003; 63: 2103-2108.
44. Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E et al. A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 2001; 61: 439-444.
45. Ruaro EM, Collavin L, DelSal G, Haffner R, Oren M, Levine AJ et al. A proline-rich motif in P53 is required for transactivation-independent growth arrest as induced by Gas1. Proc Natl Acad Sci USA 1997; 94: 4675-4680.
46. GomezManzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ et al. Adenovirus-mediated transfer of the P53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 1996; 56: 694-699.
47. Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Ilhong S, Takamoto S et al. Negative effects of wild-type P53 and S-Myc on cellular growth and tumorigenicity of glioma-cells - implication of the tumor-suppressor genes for genetherapy. J Neurooncol 1994; 19: 259-268.
48. Vanmeir EG, Roemer K, Diserens AC, Kikuchi T, Rempel SA, Haas M et al. Single-cell monitoring of growth arrest and morphological-changes induced by transfer of wild-type P53 alleles to glioblastoma cells. Proc Natl Acad Sci USA 1995; 92: 1008-1012.
49. Chen XB, Ko LJ, Jayaraman L, Prives C. P53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev 1996; 10: 2438-2451.
50. Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El Naggar AK et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 2004; 36: 63-68.
51. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-KappaB by the Akt/PKB kinase. Curr Biol 1999; 9: 601-604.
52. Ryan KM, Ernst MK, Rice NR, Vousden KH. Role of NF-KappaB in P53-mediated programmed cell death. Nature 2000; 404: 892-897.
53. Fujioka S, Schmidt C, Sclabas GM, Li Z, Pelicano H, Peng B et al. Stabilization of P53 is a novel mechanism for proapoptotic function of NF-KappaB. J Biol Chem 2004; 279: 27549-27559.
54. Bredesen DE, Mehlen P, Rabizadeh S. Apoptosis and dependence receptors: a molecular basis for cellular addiction. Physiol Rev 2004; 84: 411-430.
55. Bordeaux MC, Forcet C, Granger L, Corset V, Bidaud C, Billaud M et al. The RET proto-oncogene induces apoptosis: a novel mechanism for hirschsprung disease. EMBO J 2000; 19: 4056-4063.
56. Chen WY, Bailey EC, McCune SL, Dong JY, Townes TM. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. Proc Natl Acad Sci USA 1997; 94: 5798-5803.
57. Ho IA, Hui KM, Lam PY. Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector. Hum Gene Ther 2004; 15: 495-508.
58. Morelli AE, Larregina AT, Smith-Arica J, Dewey RA, Southgate TD, Ambar B et al. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity. J Gen Virol 1999; 80(Part 3): 571-583.
59. Wang CY, Li F, Yang Y, Guo HY, Wu CX, Wang S. Recombinant baculovirus containing the diphtheria toxin a gene for malignant glioma therapy. Cancer Res 2006; 66: 5798-5806.
60. Adachi Y, Chandrasekar N, Kin Y, Lakka SS, Mohanam S, Yanamandra N et al. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense UPAR and sense P16 gene sequences. Oncogene 2002; 21: 87-95.
61. Deng WG, Kawashima H, Wu G, Jayachandran G, Xu K, Minna JD et al. Synergistic tumor suppression by coexpression of FUS1 and P53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Cancer Res 2007; 67: 709-717.
62. Green NK, McNeish IA, Doshi R, Searle PF, Kerr DJ, Young LS. Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector. Int J Cancer 2003; 104: 104-112.
63. Huang Y, Tyler T, Saadatmandi N, Lee C, Borgstrom P, Gjerset RA. Enhanced tumor suppression by a P14ARF/P53 bicistronic adenovirus through increased P53 protein translation and stability. Cancer Res 2003; 63: 3646-3653.
64. Wiesenhofer B, Stockhammer G, Kostron H, Maier H, Hinterhuber H, Humpel C. Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-Alpha 1) are strongly expressed in human gliomas. Acta Neuropathologica 2000; 99: 131-137.
65. Mullor JL, Altaba ARI. Growth, hedgehog and the price of GAS. Bioessays 2002; 24: 22-26.
66. Altaba ARI, Stecca B, Sanchez P. Hedgehog-Gli signaling in brain tumors: stem cells and paradevelopmental programs in cancer. Cancer Lett 2004; 204: 145-157.
67. Oliver TG, Wechsler-Reya RJ. Getting at the root and stem of brain tumors. Neuron 2004; 42: 885-888.